Literature DB >> 24524374

Glucose transport in brain - effect of inflammation.

J Jurcovicova.   

Abstract

Glucose is transported across the cell membrane by specific saturable transport system, which includes two types of glucose transporters: 1) sodium dependent glucose transporters (SGLTs) which transport glucose against its concentration gradient and 2) sodium independent glucose transporters (GLUTs), which transport glucose by facilitative diffusion in its concentration gradient. In the brain, both types of transporters are present with different function, affinity, capacity, and tissue distribution. GLUT1 occurs in brain in two isoforms. The more glycosylated GLUT1 is produced in brain microvasculature and ensures glucose transport across the blood brain barrier (BBB). The less glycosylated form is localized in astrocytic end-feet and cell bodies and is not present in axons, neuronal synapses or microglia. Glucose transported to astrocytes by GLUT1 is metabolized to lactate serving to neurons as energy source. Proinflammatory cytokine interleukin (IL)-1β upregulates GLUT1 in endothelial cells and astrocytes, whereas it induces neuronal death in neuronal cell culture. GLUT2 is present in hypothalamic neurons and serves as a glucose sensor in regulation of food intake. In neurons of the hippocampus, GLUT2 is supposed to regulate synaptic activity and neurotransmitter release. GLUT3 is the most abundant glucose transporter in the brain having five times higher transport capacity than GLUT1. It is present in neuropil, mostly in axons and dendrites. Its density and distribution correlate well with the local cerebral glucose demands. GLUT5 is predominantly fructose transporter. In brain, GLUT5 is the only hexose transporter in microglia, whose regulation is not yet clear. It is not present in neurons. GLUT4 and GLUT8 are insulin-regulated glucose transporters in neuronal cell bodies in the cortex and cerebellum, but mainly in the hippocampus and amygdala, where they maintain hippocampus-dependent cognitive functions. Insulin translocates GLUT4 from cytosol to plasma membrane to transport glucose into cells, and GLUT8 from cytosol to rough endoplasmic reticulum to recover redundant glucose to cytosol after protein glycosylation. In autoimmune diseases, the enhanced glucose uptake was found in inflamed peripheral tissue, mainly due to proliferating fibroblasts and activated macrophages. In our experimental model of rheumatoid arthritis (adjuvant arthritis), enhanced 2-deoxy-2[F-18]fluoro-D-glucose was found in the hippocampus and amygdala two days after the induction of the disease which, similarly as in the peripheral joints, can be ascribed to the activated macrophages. The knowledge on the glucose transport and the role of glucose transporters in the brain during systemic autoimmune inflammation is still incomplete and needs further investigations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24524374     DOI: 10.4149/endo_2014_01_35

Source DB:  PubMed          Journal:  Endocr Regul        ISSN: 1210-0668


  38 in total

Review 1.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

2.  Immunoreactivity of glucose transporter 8 is localized in the epithelial cells of the choroid plexus and in ependymal cells.

Authors:  Ryuta Murakami; Yoichi Chiba; Kazuhito Tsuboi; Koichi Matsumoto; Machi Kawauchi; Ryuji Fujihara; Masato Mashima; Kenji Kanenishi; Tetsuji Yamamoto; Masaki Ueno
Journal:  Histochem Cell Biol       Date:  2016-05-09       Impact factor: 4.304

3.  Cognitive impairment and gene expression alterations in a rodent model of binge eating disorder.

Authors:  Anjali Chawla; Zachary A Cordner; Gretha Boersma; Timothy H Moran
Journal:  Physiol Behav       Date:  2017-08-15

Review 4.  Fluid and ion transfer across the blood-brain and blood-cerebrospinal fluid barriers; a comparative account of mechanisms and roles.

Authors:  Stephen B Hladky; Margery A Barrand
Journal:  Fluids Barriers CNS       Date:  2016-10-31

5.  Peripheral Levels of AGEs and Astrocyte Alterations in the Hippocampus of STZ-Diabetic Rats.

Authors:  Patrícia Nardin; Caroline Zanotto; Fernanda Hansen; Cristiane Batassini; Manuela Sangalli Gasparin; Patrícia Sesterheim; Carlos-Alberto Gonçalves
Journal:  Neurochem Res       Date:  2016-04-15       Impact factor: 3.996

6.  Microglia modulate brainstem serotonergic expression following neonatal sustained hypoxia exposure: implications for sudden infant death syndrome.

Authors:  P M MacFarlane; C A Mayer; D G Litvin
Journal:  J Physiol       Date:  2016-02-21       Impact factor: 5.182

Review 7.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Authors:  Steven E Arnold; Zoe Arvanitakis; Shannon L Macauley-Rambach; Aaron M Koenig; Hoau-Yan Wang; Rexford S Ahima; Suzanne Craft; Sam Gandy; Christoph Buettner; Luke E Stoeckel; David M Holtzman; David M Nathan
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

Review 8.  Modulation of Glucose Availability and Effects of Hypo- and Hyperglycemia on Status Epilepticus: What We Do Not Know Yet?

Authors:  Igor Santana de Melo; Amanda Larissa Dias Pacheco; Yngrid Mickaelli Oliveira Dos Santos; Laura Mello Figueiredo; Dannyele Cynthia Santos Pimentel Nicacio; Leia Cardoso-Sousa; Marcelo Duzzioni; Daniel Leite Góes Gitaí; Cristiane Queixa Tilelli; Robinson Sabino-Silva; Olagide Wagner de Castro
Journal:  Mol Neurobiol       Date:  2020-09-25       Impact factor: 5.590

Review 9.  Glia-neuron energy metabolism in health and diseases: New insights into the role of nervous system metabolic transporters.

Authors:  Mithilesh Kumar Jha; Brett M Morrison
Journal:  Exp Neurol       Date:  2018-07-22       Impact factor: 5.330

10.  Aging alters glucose uptake in the naïve and injured rodent spinal cord.

Authors:  Ramona E von Leden; Kasey E Moritz; Sara Bermudez; Shalini Jaiswal; Colin M Wilson; Bernard J Dardzinski; Kimberly R Byrnes
Journal:  Neurosci Lett       Date:  2018-10-06       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.